Page last updated: 2024-09-03

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and vasoactive intestinal peptide

cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) has been researched along with vasoactive intestinal peptide in 1 studies

Compound Research Comparison

Studies
(cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl))
Trials
(cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl))
Recent Studies (post-2010)
(cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl))
Studies
(vasoactive intestinal peptide)
Trials
(vasoactive intestinal peptide)
Recent Studies (post-2010) (vasoactive intestinal peptide)
250010,8731231,221

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, F; Hayes, J; Hermann, G; Malarkey, WB; O'Dorisio, MS; O'Dorisio, TM1

Other Studies

1 other study(ies) available for cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) and vasoactive intestinal peptide

ArticleYear
Mechanisms of action of long-acting analogs of somatostatin.
    Regulatory peptides, 1993, Apr-08, Volume: 44, Issue:3

    Topics: Amino Acid Sequence; Animals; Molecular Sequence Data; Octreotide; Pituitary Neoplasms; Protein Binding; Rats; Receptors, Somatostatin; Second Messenger Systems; Somatostatin; Structure-Activity Relationship; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1993